This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.
This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.

YOUR DRUG DEVELOPMENT PARTNER

Leading international contract development and manufacturing organization (CDMO).

Services

Chemical Entity

Drug Substance

  • Analytical method development and validation
  • Stability studies and Quality Control

Drug Product

  • Formulation development and GMP manufacturing (non-sterile and sterile)
  • Analytical method development and validation
  • Stability studies and Quality Control

Other Services

  • In-Life studies
  • Bioanalysis
  • Quality Control of raw materials
  • Clinical packaging and logistics
  • Regulatory support
Read More

Biological Entity

Drug Substance

  • Biological process development and GMP manufacturing
  • Analytical method development and validation
  • Stability studies and Quality Control

Drug Product

  • Formulation development and GMP manufacturing (non-sterile and sterile)
  • Analytical method development and validation
  • Stability studies and Quality Control

Other Services

  • In-Life studies
  • Quality Control of raw materials and components
  • Clinical packaging and logistics
  • Regulatory support
Proteins, mAbs, viruses and live cells, vaccines, process aids, DNA, RNA Read More

HIGH QUALITY. CUSTOMIZED. COST-EFFECTIVE.

Eurofins Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO), headquartered in France. Within Eurofins Amatsigroup, we provide high-quality, customized and cost-effective drug development solutions, integrated under one roof, to small biotech and major (bio) pharmaceutical customers. Our innovative and flexible approach enables customers to speed up their drug development process, achieving key milestones in a timely manner.

About Eurofins Amatsigroup

FROM DRUG SUBSTANCE TO DRUG PRODUCT.

Eurofins Amatsigroup has three strategic pillars:

  • Drug substance process development and manufacturing for biologics
  • Pharmaceutical analysis solutions: fit-for-purpose method developments and validations, stability studies and Quality Control (QC)
  • Formulation development and manufacturing of sterile and non-sterile clinical or small commercial batches.
Learn More

PROACTIVE SUSTAINABLE PARTNER. STRONG TRACK RECORD.

Our clients also benefit from complementary services such as in-life studies, bioanalysis and clinical trial supply (packaging & logistics). A broad scientific, technical and regulatory expertise, combined with proactive troubleshooting skills, are the key assets of the company. Our goal is to build a sustainable partnership with our customers to support their drug development pathway.

Learn More

CONTACT US

Your message has been sent.

I’m
your name
from
your company,
your region
. I would like to discuss
select a topic
so please call me at
your phone number
or send an e-mail to
your e-mail address
and
leave your message.